Development asset linked to Aura Biosciences in public FDA and regional records.
biotech · Uveal Melanoma · Choroidal Melanoma · AURA
Aura Biosciences
Aura Biosciences drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Boston, USA HQ
2009 Founded
128 Employees
Public company Type
AURA · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Founded
- 2009
- Employees
- 128
- Programs
- 6
- Drugs
- 3
- Patents
- 17
Aura Biosciences pipeline
Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Aura Biosciences drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Aura Biosciences in public FDA and regional records.
-
Development asset linked to Aura Biosciences in public FDA and regional records.